Other Events ·
At its Annual Meeting of Stockholders on June 25, 2026, Myomo, Inc. stockholders approved an amendment to the…
MYOMyomo, Inc.
At its Annual Meeting of Stockholders on June 25, 2026, Myomo, Inc. stockholders approved an amendment to the company's Eighth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock to 100,000,000. Additionally, stockholders approved Amendment No. 3 to the Myomo 2018 Stock Option and Incentive Plan, increasing the number of shares available under the plan by 1,833,000 shares. Other approved items included the election of Paul R. Gudonis and Thomas F. Kirk as Class III directors and the ratification of CBIZ CPAs P.C. as the independent registered public accounting firm for fiscal year 2026. Myomo, Inc. operates in the healthcare technology industry, providing robotic assistive devices for individuals with neuromuscular disorders.